Ignite Creation Date:
2025-12-24 @ 9:20 PM
Ignite Modification Date:
2026-03-19 @ 3:33 PM
Study NCT ID:
NCT04088604
Status:
COMPLETED
Last Update Posted:
2023-04-26
First Post:
2019-08-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid Tumors
Sponsor:
Luye Pharma Group Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LY01610/CT-CHN-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None